Cost of control was calculated by dividing treatment costs by the proportion of patients achieving each target
Its a major advance for public health in a population with an elevated risk of severe cardiovascular outcomes, the FDA Center for Drug Evaluation and Researchs head of diabetes, lipid disorders and obesity, John Sharretts, M.D., said in the agencys release
It says shared decision-making between patient and provider should determine whether reaching 15 mg aligns with individual health goals, tolerability profile and comorbidity management
After this initial period, the dose is increased to 5 mg weekly, with further increases to 7.5 mg, 10 mg, 12.5 mg, and a maximum of 15 mg occurring at four-week intervals based on individual response and tolerability
Many patients seeking weight loss injections prefer this compounded blend to help manage the common side effects of caloric restriction
Obesity is an independent risk factor for GERD symptoms and erosive esophagitis